For example, anti-catabolic agents (e.g., an inhibitor of osteoclast activity or a specific inhibitor of RANKL) halt MM-induced bone resorption and result in inhibition of MM cell proliferation and survival [62], [63]. The gene discussed is TNFSF11; the disease is Miyoshi myopathy.